Myelofibrosis (MF)
Myelofibrosis is a type of blood cancer that causes scar tissue to form in your bone marrow (the spongy material inside some of your bones, where blood cells are made).
Myelofibrosis at a glance
Myelofibrosis is a type of blood cancer. It belongs to a group of conditions that affect the blood called myeloproliferative neoplasms (MPN).
Myelofibrosis happens when scar tissue builds up in your bone marrow (the soft spongy material inside some of your bones, where blood cells are made). This stops your blood cells from developing properly.
Sign up to our weekly support email for people recently diagnosed.
It gives you clear and simple information, practical tips and advice from others with blood cancer, to help during the first few weeks and months after diagnosis.
If someone you love has been diagnosed with non-Hodgkin lymphoma, you might find our information for family and friends helpful. It covers how to support someone with blood cancer, practical tips, coping with your own emotions, and real stories from other friends and family members.
You may also want to try our podcast for family and friends, Blood Cancer Heart to Heart, featuring honest conversations between people who know what it's like to have a loved one diagnosed with blood cancer.
People with myelofibrosis may experience breathlessness, unusual bleeding and bruising.
Another common symptom is a reduced ability to fight infection. Your GP may send you for blood tests to confirm a diagnosis.
Find out more about the symptoms and diagnosis of myelofibrosis
The treatment you have will depend on certain factors, including your blood counts, the symptoms you have and how fit you are. Some people don’t need treatment straight away.
Prognosis (outlook) can vary and will depend on how slowly or quickly the myelofibrosis is developing. Your prognosis is individual to you and your healthcare team can give you the best information.
Clinical trials are how we find new treatments and improve current ones. We can help you find out about clinical trials for myelofibrosis. Even if you just want to know a bit more about myelofibrosis research, try our Clinical Trials Support Service.
Our previous research has focused on improving treatments for blood cancers. Read about our research impact.
Get a weekly support email from us
We'll send you clear and simple information, practical tips, and advice from other people with blood cancer, to help during the first few weeks and months after diagnosis.
